Showing results (641-650 of 8,120) with videos related to
Sort By:
Pageof 812
Haematologica|June 11, 2009
Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell populationBelén Blanco, José A Pérez-Simón, Luis I Sánchez-Abarca, et al.Haematologica|March 17, 2009
F9 Malmö, factor IX and deep vein thrombosisIrene D Bezemer, Andre R Arellano, Carmen H Tong, et al.Haematologica|March 17, 2009
Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemiaLynn R Goldin, Magnus Björkholm, Sigurdur Y Kristinsson, et al.Haematologica|May 2, 2009
Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromesTerry J Gaymes, Sydney Shall, Lee J MacPherson, et al.Haematologica|May 2, 2009
Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administrationErsi Voskaridou, Dimitrios Christoulas, Charoula Xirakia, et al.Haematologica|October 8, 2008
Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemiaJean-Valère Malfuson, Anne Etienne, Pascal Turlure, et al.Haematologica|October 8, 2008
Chromosomal instability syndromes are sensitive to poly ADP-ribose polymerase inhibitorsTerry J Gaymes, Sydney Shall, Farzin Farzaneh, et al.Haematologica|October 8, 2008
Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-upFrancesca Palandri, Fausto Castagnetti, Nicoletta Testoni, et al.Haematologica|December 9, 2008
Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98BRichard F Schlenk, Konstanze Döhner, Michael Kneba, et al.Pageof 812